About the Company
Orum Therapeutics is a private biotech company located in Daejeon, Korea, and Cambridge, Massachusetts. Orum is building a unique cell-penetrating antibody platform, Oromab, to allow recognition of cytosolic targets that are currently “undruggable” by small molecules or biologics. Using Oromab, antibodies can be engineered to directly target disease-causing intracellular proteins for inhibition of oncogenic drivers or delivery of oligonucleotides and enzymes to treat cancer and rare diseases.
See here for a news article with more info. on the company and its technology.
About the Opportunity
Orum is seeking MIT students with interest in developing new, innovative drugs. Potential internship projects may include but are not limited to the following:
- Antibody engineering
- Virtual screening, computational chemistry, protein modeling based on super-computing and machine learning
- Intellectual property
- Business development
Internships of 3-12 months are available throughout the year, and funding is provided for all basic internship expenses, including airfare, housing, and living costs.
Class year: 1st year, sophomore, junior, senior, master’s, Ph.D.
Course: Biology (7), Biological Engineering (20), Chemical-Biological Engineering (10-B), Computer Science & Engineering (6-3), Computer Science & Molecular Biology (6-7), Management (15).
Applicants must meet MISTI MIT-Korea requirements prior to the internship start date:
- Undergraduate students must complete 4 semesters of Korean language courses or have similar proficiency. Graduate students may have this requirement waived.
- Completion of MIT-Korea pre-internship training, 10-15 total hrs.
- Minimum 4.0 GPA
The priority application deadline for summer internships is Nov. 30; applications are only accepted after that date if positions are still available. Submit applications for non-summer internships at least 3 months before desired start date.
(Orum Therapeutics is eligible for Korea’s alternative military service employment of male Korean citizen applicants with a Master’s degree and above.)